Skip to content
Open access

Extent of resection and adjuvant radiotherapy in intracranial anaplastic meningioma: improved disease control with no statistically significant overall survival benefit

Sep 2026 · Frontiers in Surgery · Vol 13 · 0 citations · 29 references
Medicine

TL;DR

In this cohort, neither extent of resection nor adjuvant radiotherapy reached a statistically significant improvement in overall survival, whereas both were associated with delayed tumor recurrence.

Abstract

Background Intracranial anaplastic meningioma, currently classified as World Health Organization (WHO) Grade III, is a rare and biologically aggressive tumor with a high recurrence rate. Due to its rarity, the available literature on its clinical characteristics and prognostic factors remains limited. In this study, we aimed to evaluate the relative impact of the extent of surgical resection and adjuvant radiotherapy on long-term survival and recurrence control in patients with intracranial anaplastic meningioma. Methods We conducted a retrospective cohort study of patients with histopathologically confirmed World Health Organization (WHO) Grade III meningioma. Among 5,962 cases treated between January 2012 and July 2022, 46 patients with complete follow-up data were included. Clinical characteristics, treatment modalities, and outcomes were analyzed. Kaplan–Meier analysis was used to assess progression-free survival (PFS) and overall survival (OS). Results During follow-up, 38 patients (82.6%) experienced tumor recurrence. The median PFS was 24 months, with 2- and 5-year recurrence rates of 52.0% and 77.0%, respectively. The median OS was 68 months, with 2- and 5-year OS rates of 79.7% and 56.5%. Simpson Grade I/II resection was associated with longer OS than Grade III/IV resection, although the difference was not statistically significant. Adjuvant radiotherapy showed a trend toward improved OS but did not reach statistical significance. In contrast, radiotherapy was associated with delayed recurrence and prolonged PFS, particularly in terms of early recurrence control. Conclusions Intracranial anaplastic meningioma is characterized by high recurrence and poor prognosis. In this cohort, neither extent of resection nor adjuvant radiotherapy reached a statistically significant improvement in overall survival, whereas both were associated with delayed tumor recurrence. These findings suggest that current treatment strategies may primarily provide temporal disease control rather than substantially altering long-term survival outcomes.

Read PDF

Similar papers

Review Open access Aug 2026

Postoperative functional status as the primary determinant of survival in surgically treated brain metastases: A retrospective cohort analysis

Initial univariable screening showed that survival was significantly linked to factors such as patient age, gender, adjuvant therapies, and KPS measured at different perioperative stages, which showed that survival was significantly linked to factors such as patient age, gender, adjuvant therapies, and KPS measured at...

M. O. Özateş, Kadir Çetinkaya, Yaşar Ünsal et al. · 0 citations
Sep 2026

Increased risk of early recurrence after gross-total resection in males with a WHO grade II meningioma: the impact of sex on recurrence and death in 5441 meningioma patients.

In this observational cohort, males with WHO grade II meningiomas who received GTR had a higher risk of early recurrence than females, an effect that appeared to be age dependent, raising the possibility of biological contributions linked to sex hormones.

Anders Broechner, Lasse Rehné Jensen, T. Juratli et al. · 0 citations
Open access Sep 2026

Early and Late Prognostic Factors in Patients with Resected Brain Metastases

Simple Summary Brain metastases are among the most common intracranial tumors in adults, and outcomes after surgical treatment vary considerably among patients. This retrospective study analyzed 378 consecutive adults who underwent resection of histologically confirmed brain metastases at Bagdasar-Arseni Clinical Emerg...

Dan M. Visarion, I. Petrescu, V. Prună et al. · 0 citations
Oct 2026

Impact of Extent of Surgical Resection on Survival in Patients With High-risk Neuroblastoma: A Report From Children's Oncology Group ANBL0532.

OBJECTIVE The impact of extent of resection of the primary tumor on outcomes in patients with high-risk neuroblastoma (HRNB) remains uncertain. We evaluated this issue in patients with HRNB treated on a prospective trial of multimodality therapy. SUMMARY OF BACKGROUND DATA Patients with HRNB enrolled on COG ANBL0532...

C. Grant, Arlene Naranjo, Fan F. Zhang et al. · 0 citations
Review Open access Sep 2026

Impact of primary tumor resection on survival in high-risk neuroblastoma: a long-term single-center study

The prognostic value of primary tumor resection in high-risk neuroblastoma (HrNB) remains controversial. While several Western studies have suggested a survival benefit of complete resection, our institution has not observed a clear association. We therefore evaluated the long-term impact of surgical resection, particu...

N. Kawakubo, Junnosuke Maniwa, Y. Toriigahara et al. · 0 citations
Open access Aug 2026

Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023

Despite advances in diagnosis and treatment, locally recurrent rectal cancer (LRRC) remains a complex condition associated with a poor prognosis. This study aimed to evaluate long-term trends in the management of and oncological outcomes for patients with LRRC treated in a Dutch tertiary referral center. All consecutiv...

F. E. C. Vande Kerckhove, D. Creemers, E. Banken et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.